A M I No 14.247/2024 25 Cap/tab Primidone 50mg
Tender Title | A M I No 14.247/2024 25 Cap/tab Primidone 50mg | ||
Tender ID | NA | Tender Reference Number | 82242124 |
Tender Type | Limited | ||
Tender Opening Date | 2024-09-13 05:08 AM | Tender Closing Date | 2024-09-24 05:30 AM |
Tender Value | Refer Document | Tender Location | New Delhi , Central Delhi , Delhi |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2024-09-13 05:08 AM | Bid Opening Date | 2024-09-24 05:30 AM |
Document Download Start Date | 2024-09-13 05:08 AM | Document Download End Date | 2024-09-24 05:30 AM |
Bid Submission Start Date | 2024-09-13 05:08 AM | Bid Submission End Date | 2024-09-24 05:30 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | Refer document |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, Stores/Northern Rly, is inviting bids for the supply of "Cap/Tab Primidone 50mg" under Tender Reference Number 82242124. This is a limited tender for railway-related goods, with a closing date of 24-Sep-2024 at 11:00 AM. The tender documents can be downloaded from 13-Sep-2024 at 10:38 AM. Interested parties can submit bids from the same date until the closing date. This tender requires no tender fee or EMD. For detailed information regarding the scope of work and specifications, please refer to the tender document.
Office Inviting Bids | Stores/northern Rly |
Address | 2nd Floor, Annexe- I Baroda House, K G Marg New Delhi |
Contact Details | NA |
NA | |
Website | NA |
A M I No - 14.203/2024-25 Cap/tab Levodopa 200mg And Carbidopa 50mg Cr..read more
A M I No - 14.148/2024-25 Cap/tab Clozapine 25mg..read more
A M I No. 10.225 / 2024-25 Tab/cap. Warfarin 2mg..read more
A M I No - 16.269/2024-25 Tab/cap Temozolamide 20mg..read more
A M I No - 14.164/2024-25 Cap/tab Doxepin 25mg..read more